irinotecan has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, R; Hakusui, H; Okazaki, O | 1 |
| Furuta, T; Mutai, M; Yokokura, T | 1 |
2 other study(ies) available for irinotecan and Carcinoma 256, Walker
| Article | Year |
|---|---|
Metabolism of irinotecan to SN-38 in a tissue-isolated tumor model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma 256, Walker; Cattle; Chromatography, High Pressure Liquid; Female; Irinotecan; Ovarian Neoplasms; Rats; Rats, Wistar; Tumor Cells, Cultured | 1995 |
[Antitumor activity of CPT-11 against rat Walker 256 carcinoma].
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma 256, Walker; Infusions, Intravenous; Infusions, Parenteral; Irinotecan; Rats | 1988 |